Exicure regains Nasdaq compliance but faces one-year monitoring period with risk of immediate delisting if violated

EXICURE, INC.

On Dec 20, 2024, Nasdaq confirmed Exicure meets all requirements for continued listing as of Dec 17, 2024.
Company had previously been notified of non-compliance with $2.5M stockholders' equity requirement; its deficit was $2.2M as of Mar 31, 2024.
Exicure is now subject to a one-year Mandatory Panel Monitor; any future non-compliance could result in immediate delisting without a cure period.
The company achieved compliance through transactions disclosed in a Dec 17, 2024 Form 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.